MERIT MEDICAL SYSTEMS INC Selling, General and Administrative Expense
MERIT MEDICAL SYSTEMS INC (MMSI) reported Selling, General and Administrative Expense of $129.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-30
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for the quarter ending 2026-06-30 was $129.23M, a 14.26% increase year-over-year.
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for the quarter ending 2026-03-31 was $118.21M, a 9.98% increase year-over-year.
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for the quarter ending 2025-12-31 was $114.83M, a 3.38% increase year-over-year.
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for the quarter ending 2025-09-30 was $119.80M, a 20.23% increase year-over-year.
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for fiscal 2025 was $455.21M, a 13.88% increase from fiscal 2024.
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for fiscal 2024 was $399.73M, a 6.97% increase from fiscal 2023.
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for fiscal 2023 was $373.68M, a 9.09% increase from fiscal 2022.
- MERIT MEDICAL SYSTEMS INC selling, general and administrative expense for fiscal 2022 was $342.52M, a 2.04% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129.23M 10-Q · filed 2026-07-30 | $247.44M 10-Q · filed 2026-07-30 | $362.27M derived: sum of 3 quarters · filed 2026-07-30 | $482.07M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $118.21M 10-Q · filed 2026-04-30 | $233.04M derived: sum of 2 quarters · filed 2026-04-30 | $352.84M derived: sum of 3 quarters · filed 2026-04-30 | $465.94M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $114.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $234.63M derived: sum of 2 quarters · filed 2026-02-24 | $347.73M derived: sum of 3 quarters · filed 2026-07-30 | $455.21M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $119.80M 10-Q · filed 2025-10-30 | $232.90M derived: sum of 2 quarters · filed 2026-07-30 | $340.38M 10-Q · filed 2025-10-30 | $451.46M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $113.10M 10-Q · filed 2026-07-30 | $220.58M 10-Q · filed 2026-07-30 | $331.66M derived: sum of 3 quarters · filed 2026-07-30 | $431.30M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $107.49M 10-Q · filed 2026-04-30 | $218.56M derived: sum of 2 quarters · filed 2026-04-30 | $318.20M derived: sum of 3 quarters · filed 2026-04-30 | $412.79M derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $111.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $210.72M derived: sum of 2 quarters · filed 2026-02-24 | $305.30M derived: sum of 3 quarters · filed 2026-02-24 | $399.73M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $99.64M 10-Q · filed 2025-10-30 | $194.23M derived: sum of 2 quarters · filed 2025-10-30 | $288.66M 10-Q · filed 2025-10-30 | $384.41M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $94.58M 10-Q · filed 2025-07-30 | $189.01M 10-Q · filed 2025-07-30 | $284.76M derived: sum of 3 quarters · filed 2026-02-24 | $371.62M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $94.43M 10-Q · filed 2025-04-24 | $190.18M derived: sum of 2 quarters · filed 2026-02-24 | $277.03M derived: sum of 3 quarters · filed 2026-02-24 | $377.96M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $95.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $182.60M derived: sum of 2 quarters · filed 2026-02-24 | $283.53M derived: sum of 3 quarters · filed 2026-02-24 | $373.68M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $86.85M 10-Q · filed 2024-10-30 | $187.78M derived: sum of 2 quarters · filed 2024-10-30 | $277.93M 10-Q · filed 2024-10-30 | $361.17M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $100.93M 10-Q · filed 2024-08-01 | $191.07M 10-Q · filed 2024-08-01 | $274.31M derived: sum of 3 quarters · filed 2025-02-25 | $364.09M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $90.14M 10-Q · filed 2024-04-30 | $173.39M derived: sum of 2 quarters · filed 2025-02-25 | $263.17M derived: sum of 3 quarters · filed 2025-02-25 | $348.65M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $83.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $173.02M derived: sum of 2 quarters · filed 2025-02-25 | $258.51M derived: sum of 3 quarters · filed 2025-02-25 | $342.52M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $89.78M 10-Q · filed 2023-10-26 | $175.27M derived: sum of 2 quarters · filed 2023-10-26 | $259.28M 10-Q · filed 2023-10-26 | $335.91M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $85.49M 10-Q · filed 2023-07-28 | $169.50M 10-Q · filed 2023-07-28 | $246.13M derived: sum of 3 quarters · filed 2024-02-28 | $332.61M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $84.02M 10-Q · filed 2023-04-28 | $160.64M derived: sum of 2 quarters · filed 2024-02-28 | $247.12M derived: sum of 3 quarters · filed 2024-02-28 | $338.68M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $76.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $163.10M derived: sum of 2 quarters · filed 2024-02-28 | $254.67M derived: sum of 3 quarters · filed 2024-02-28 | $335.69M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $86.47M 10-Q · filed 2022-10-28 | $178.04M derived: sum of 2 quarters · filed 2022-10-28 | $259.06M 10-Q · filed 2022-10-28 | $339.00M derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-06-30 | $91.56M 10-Q · filed 2022-08-05 | $172.59M 10-Q · filed 2022-08-05 | $252.52M derived: sum of 3 quarters · filed 2023-02-24 | $324.74M derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-03-31 | $81.02M 10-Q · filed 2022-05-06 | $160.96M derived: sum of 2 quarters · filed 2023-02-24 | $233.17M derived: sum of 3 quarters · filed 2023-02-24 | $299.94M derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2020-12-31 | $79.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $152.15M derived: sum of 2 quarters · filed 2023-02-24 | $218.92M derived: sum of 3 quarters · filed 2023-02-24 | $297.72M 10-K · filed 2023-02-24 | ||
| 2020-09-30 | $72.22M 10-Q · filed 2021-11-05 | $138.98M derived: sum of 2 quarters · filed 2021-11-05 | $217.79M 10-Q · filed 2021-11-05 | $299.88M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $66.77M 10-Q · filed 2021-08-06 | $145.57M 10-Q · filed 2021-08-06 | $227.67M derived: sum of 3 quarters · filed 2022-03-01 | $314.60M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $78.81M 10-Q · filed 2021-05-07 | $160.90M derived: sum of 2 quarters · filed 2022-03-01 | $247.84M derived: sum of 3 quarters · filed 2022-03-01 | $327.81M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $82.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $169.03M derived: sum of 2 quarters · filed 2022-03-01 | $249.00M derived: sum of 3 quarters · filed 2022-03-01 | $327.27M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $86.94M 10-Q · filed 2020-11-05 | $166.91M derived: sum of 2 quarters · filed 2020-11-05 | $245.18M 10-Q · filed 2020-11-05 | $320.81M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $79.98M 10-Q · filed 2020-08-06 | $158.25M 10-Q · filed 2020-08-06 | $233.88M derived: sum of 3 quarters · filed 2021-03-01 | $300.26M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $78.27M 10-Q · filed 2020-05-11 | $153.90M derived: sum of 2 quarters · filed 2021-03-01 | $220.28M derived: sum of 3 quarters · filed 2021-03-01 | $289.38M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $75.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $142.01M derived: sum of 2 quarters · filed 2021-03-01 | $211.11M derived: sum of 3 quarters · filed 2021-03-01 | $276.02M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $66.38M 10-Q · filed 2019-11-08 | $135.48M derived: sum of 2 quarters · filed 2019-11-08 | $200.39M 10-Q · filed 2019-11-08 | $259.63M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $69.09M 10-Q · filed 2019-08-09 | $134.01M 10-Q · filed 2019-08-09 | $193.25M derived: sum of 3 quarters · filed 2020-03-02 | $247.96M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $64.91M 10-Q · filed 2019-05-03 | $124.15M derived: sum of 2 quarters · filed 2020-03-02 | $178.87M derived: sum of 3 quarters · filed 2020-03-02 | $236.28M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $59.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $113.95M derived: sum of 2 quarters · filed 2020-03-02 | $171.36M derived: sum of 3 quarters · filed 2020-03-02 | $229.13M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $54.72M 10-Q · filed 2018-11-09 | $112.13M derived: sum of 2 quarters · filed 2018-11-09 | $169.90M 10-Q · filed 2018-11-09 | $215.74M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $57.41M 10-Q · filed 2018-08-09 | $115.18M 10-Q · filed 2018-08-09 | $161.02M derived: sum of 3 quarters · filed 2019-03-01 | $214.22M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $57.77M 10-Q · filed 2018-05-10 | $103.61M derived: sum of 2 quarters · filed 2019-03-01 | $156.81M derived: sum of 3 quarters · filed 2019-03-01 | $200.46M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2016-12-31 | $45.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $99.04M derived: sum of 2 quarters · filed 2019-03-01 | $142.69M derived: sum of 3 quarters · filed 2019-03-01 | $184.40M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $53.20M 10-Q · filed 2017-11-09 | $96.85M derived: sum of 2 quarters · filed 2017-11-09 | $138.56M 10-Q · filed 2017-11-09 | $179.50M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $43.65M 10-Q · filed 2017-08-07 | $85.36M 10-Q · filed 2017-08-07 | $126.30M derived: sum of 3 quarters · filed 2018-03-01 | $165.50M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2016-03-31 | $41.70M 10-Q · filed 2017-05-10 | $82.64M derived: sum of 2 quarters · filed 2018-03-01 | $121.85M derived: sum of 3 quarters · filed 2018-03-01 | $161.17M derived: sum of 4 quarters · filed 2018-03-01 | ||
| 2015-12-31 | $40.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $80.14M derived: sum of 2 quarters · filed 2018-03-01 | $119.46M derived: sum of 3 quarters · filed 2018-03-01 | $156.35M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $39.20M 10-Q · filed 2016-11-09 | $78.52M derived: sum of 2 quarters · filed 2016-11-09 | $115.41M 10-Q · filed 2016-11-09 | $151.62M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $39.32M 10-Q · filed 2016-08-08 | $76.21M 10-Q · filed 2016-08-08 | $112.42M derived: sum of 3 quarters · filed 2017-03-01 | $148.75M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $36.88M 10-Q · filed 2016-05-09 | $73.10M derived: sum of 2 quarters · filed 2017-03-01 | $109.42M derived: sum of 3 quarters · filed 2017-03-01 | $148.02M derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $36.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $72.54M derived: sum of 2 quarters · filed 2017-03-01 | $111.13M derived: sum of 3 quarters · filed 2017-03-01 | $147.89M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $36.33M 10-Q · filed 2015-11-09 | $74.92M derived: sum of 2 quarters · filed 2015-11-09 | $111.68M 10-Q · filed 2015-11-09 | $145.32M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $38.59M 10-Q · filed 2015-08-07 | $38.60M 10-Q · filed 2014-08-11 | $75.35M 10-Q · filed 2015-08-07 | $75.37M 10-Q · filed 2014-08-11 | $108.99M derived: sum of 3 quarters · filed 2016-02-29 | $140.34M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $36.76M 10-Q · filed 2015-05-11 | $36.77M 10-Q · filed 2014-05-09 | $70.40M derived: sum of 2 quarters · filed 2016-02-29 | $101.75M derived: sum of 3 quarters · filed 2016-02-29 | $133.31M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $33.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $64.99M derived: sum of 2 quarters · filed 2016-02-29 | $96.55M derived: sum of 3 quarters · filed 2016-02-29 | $128.64M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $31.35M 10-Q · filed 2014-11-10 | $62.91M derived: sum of 2 quarters · filed 2014-11-10 | $95.00M 10-Q · filed 2014-11-10 | $128.50M derived: sum of 4 quarters · filed 2015-03-05 | ||
| 2013-06-30 | $31.56M 10-Q · filed 2014-08-11 | $63.69M 10-Q · filed 2014-08-11 | $97.15M derived: sum of 3 quarters · filed 2015-03-05 | $126.03M derived: sum of 4 quarters · filed 2015-03-05 | ||
| 2013-03-31 | $32.13M 10-Q · filed 2014-05-09 | $65.60M derived: sum of 2 quarters · filed 2015-03-05 | $94.48M derived: sum of 3 quarters · filed 2015-03-05 | $124.69M derived: sum of 4 quarters · filed 2015-03-05 | ||
| 2012-12-31 | $33.47M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $62.35M derived: sum of 2 quarters · filed 2015-03-05 | $92.56M derived: sum of 3 quarters · filed 2015-03-05 | $122.11M 10-K · filed 2015-03-05 | ||
| 2012-09-30 | $28.88M 10-Q · filed 2013-11-12 | $59.09M derived: sum of 2 quarters · filed 2013-11-12 | $88.64M 10-Q · filed 2013-11-12 | $116.67M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-06-30 | $30.21M 10-Q · filed 2013-08-09 | $59.76M 10-Q · filed 2013-08-09 | $87.79M derived: sum of 3 quarters · filed 2014-03-12 | $113.49M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-03-31 | $29.55M 10-Q · filed 2013-05-10 | $57.58M derived: sum of 2 quarters · filed 2014-03-12 | $83.28M derived: sum of 3 quarters · filed 2014-03-12 | $109.46M derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2011-12-31 | $28.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $53.74M derived: sum of 2 quarters · filed 2014-03-12 | $79.91M derived: sum of 3 quarters · filed 2014-03-12 | $104.50M 10-K · filed 2014-03-12 | ||
| 2011-09-30 | $25.71M 10-Q · filed 2012-11-09 | $51.88M derived: sum of 2 quarters · filed 2012-11-09 | $76.47M 10-Q · filed 2012-11-09 | $102.64M derived: sum of 4 quarters · filed 2013-03-01 | ||
| 2011-06-30 | $26.18M 10-Q · filed 2012-08-09 | $50.77M 10-Q · filed 2012-08-09 | $76.93M derived: sum of 3 quarters · filed 2013-03-01 | $99.41M derived: sum of 4 quarters · filed 2013-03-01 | ||
| 2011-03-31 | $24.59M 10-Q · filed 2012-05-10 | $50.76M derived: sum of 2 quarters · filed 2013-03-01 | $73.23M derived: sum of 3 quarters · filed 2013-03-01 | $93.17M derived: sum of 4 quarters · filed 2013-03-01 | ||
| 2010-12-31 | $26.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $48.64M derived: sum of 2 quarters · filed 2013-03-01 | $68.58M derived: sum of 3 quarters · filed 2013-03-01 | $87.61M 10-K · filed 2013-03-01 | ||
| 2010-09-30 | $22.48M 10-Q · filed 2011-11-08 | $42.42M derived: sum of 2 quarters · filed 2011-11-08 | $61.45M 10-Q · filed 2011-11-08 | |||
| 2010-06-30 | $19.94M 10-Q · filed 2011-08-08 | $38.97M 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | $64.79M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |